Kevin Mellem received his PhD in organic chemistry from Harvard University in 2013. After a postdoctoral research fellowship with Professor Andrew G. Myers, Kevin joined the start-up company Revolution Medicines as one of its first two chemists.

Want to learn more about Kevin's research and career path?

Read this feature article from his alma mater, University of South Dakota.